Forbion
Forbion is a leading European venture capital firm that helps companies bridge research and development through the team's expertise in drug development and company building. Forbion's investors include the European Investment Fund (EIF), notably through its European Recovery Programme (ERP), LfA, the Dutch Venture Initiative (DVI) and AMUF facilities, and the Kreditanstalt für Wiederaufbau (KFW) through the ERP - Venture Capital Fondsfinanzierung facility. The Forbion team is spread across three offices in The Netherlands, Germany and Singapore. Primary contact
Gooimeer 2-35
1411 DC Naarden
Netherlands
+31 35 699 30 00
Gooimeer 2-35
1411 DC Naarden
Netherlands
+31 35 699 30 00
Links
https://forbion.com/
https://forbion.com/
Key people 🧑🤝🧑
- Sander Slootweg, MSc - Managing Partner
- Geert-Jan Mulder, MD - Managing Partner
- Martien van Osch, MSc - Managing Partner
- Holger Reithinger, PhD - General Partner
- Jasper Bos, PhD - General Partner
- Marco Boorsma, PhD - General Partner
- Nanna Lüneborg, PhD, MBA - General Partner
- Rogier Rooswinkel, PhD - General Partner
- Wouter Joustra, MSc - General Partner
Video ▶️
Investments 💸
AM-Pharma
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
📍 Utrecht, Netherlands
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
📍 Utrecht, Netherlands
Last update: November 22, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more


